Freedman B I, Espeland M A, Heise E R, Adams P L, Buckalew V M, Canzanello V J
Department of Medicine/Nephrology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27103.
Am J Hypertens. 1991 May;4(5 Pt 1):393-8. doi: 10.1093/ajh/4.5.393.
Black patients with hypertension are six times more likely to develop end-stage renal disease than are their white counterparts. To determine if genetic differences associated with the Human Leukocyte Antigen (HLA) system account for racial variation in hypertensive renal failure, we examined antigenic frequencies from a large renal transplant registry. Human Leukocyte Antigen phenotypes from cadaveric renal transplant recipients and donors in the South Eastern Organ Procurement Foundation database from 1982 to 1986 were analyzed. One thousand six hundred four renal transplant recipients with hypertensive renal failure as the cause of end stage renal disease (cases) were compared with 4506 race-matched cadaveric kidney donors (controls). Log-linear models were used to assess the relationship between hypertensive renal failure and prevalence of each HLA phenotype. Bonferroni adjustments of P values were used to correct for multiple comparisons. Comparison of HLA frequencies between blacks and whites with hypertensive renal failure demonstrated that blacks had an increased frequency of HLA-DR3 beyond that normally known to exist between black and white populations. Black cases compared to black controls had an 8.6% increase in HLA-DR3 frequency contrasted with a 1.6% decrease in the frequency of this antigen between white cases and white controls. This absolute 10.2% difference between the races was significant (P = .02) because the control black and white populations had nearly identical frequencies for this antigen. White cases compared to white controls had lower HLA-A1 and B8 frequencies (21.2% v 30.6%, P = .0005 and 13.7% v 22.3%, P = .001, respectively) and a greater HLA-B35 frequency (20.7% v 14.2%, P = .02).(ABSTRACT TRUNCATED AT 250 WORDS)
患有高血压的黑人发展为终末期肾病的可能性是白人的六倍。为了确定与人类白细胞抗原(HLA)系统相关的基因差异是否导致高血压性肾衰竭的种族差异,我们检查了一个大型肾脏移植登记处的抗原频率。分析了1982年至1986年东南器官采购基金会数据库中尸体肾移植受者和供者的人类白细胞抗原表型。将1604例因高血压性肾衰竭导致终末期肾病的肾移植受者(病例)与4506例种族匹配的尸体肾供者(对照)进行比较。使用对数线性模型评估高血压性肾衰竭与每种HLA表型患病率之间的关系。采用Bonferroni法调整P值以校正多重比较。对患有高血压性肾衰竭的黑人和白人的HLA频率进行比较,结果显示黑人的HLA-DR3频率高于黑人和白人人群之间通常已知的频率。与黑人对照相比,黑人病例的HLA-DR3频率增加了8.6%,而白人病例与白人对照之间该抗原的频率下降了1.6%。种族之间这10.2%的绝对差异具有统计学意义(P = .02),因为对照的黑人和白人人群中该抗原的频率几乎相同。与白人对照相比,白人病例的HLA-A1和B8频率较低(分别为21.2%对30.6%,P = .0005;13.7%对22.3%,P = .001),而HLA-B35频率较高(20.7%对14.2%,P = .02)。(摘要截断于250字)